Persistent digestive dysfunction affects millions of adults, yet distinguishing between similar-seeming conditions remains clinically challenging. Understanding when chronic diarrhea signals irritable bowel syndrome versus purely functional disorders could reshape treatment approaches and patient outcomes. This comprehensive clinical review synthesizes current diagnostic frameworks and therapeutic interventions for the two most prevalent forms of chronic, noninfectious diarrhea. The analysis distinguishes irritable bowel syndrome with diarrhea (IBS-D) from functional diarrhea, conditions that share symptomatic overlap but respond to different management strategies. Key diagnostic criteria emphasize symptom duration, associated abdominal pain patterns, and exclusion of inflammatory markers. Treatment protocols now incorporate targeted dietary modifications, including low-FODMAP approaches, alongside pharmacological interventions ranging from antispasmodics to newer gut-brain axis modulators. The review represents a significant consolidation of evidence-based practices that have evolved considerably over the past decade. Previous approaches often conflated these conditions or relied on outdated elimination protocols. Modern understanding recognizes the distinct pathophysiology underlying each disorder, with IBS-D involving altered gut-brain signaling and visceral hypersensitivity, while functional diarrhea primarily reflects motility dysfunction without pain components. For health-conscious adults experiencing persistent digestive issues, this clinical framework offers more precise diagnostic pathways and personalized treatment options. The emphasis on symptom-based diagnosis, rather than extensive invasive testing, could reduce healthcare costs while improving patient satisfaction. However, the review acknowledges ongoing challenges in standardizing treatment responses and predicting which patients will benefit from specific interventions, suggesting this remains an evolving field requiring continued research.